Datamonitor
From Wikipedia, the free encyclopedia
| Datamonitor | |
| Type | Public (SETS: [1]) |
|---|---|
| Founded | 1989 |
| Headquarters | London, United Kingdom |
| Key people | Mike Danson, CEO Simon Pyper, CFO |
| Industry | Consulting |
| Website | / www.datamonitor.com |
Datamonitor is a provider of online database and analysis services. The company is based in the United Kingdom and also has offices in the United States, Japan, and other countries.[1] The Datamonitor team includes analysts and professional researchers. They provides online data, analytic and forecasting for six industry sectors: Automotive, Consumer markets, Energy, Financial services, Health care and Technology. Datamonitor is listed on the London Stock Exchange and is also the parent company of Verdict Research.
Datamonitor produces an annual report, titled Build A Better Mousetrap in which Datamonitor identifies their picks for the best new food, drink, health, household, and pet products of the year.[2] Other reports have covered topics such as outsourcing,[3][4] and pharmaceutical industry trends.[5]
[edit] List of historical company events
- 2007 - acquires Ovum PLC
- 2006 - opens an office in Hyderabad, India and acquires Life Science Analytics Inc (“LSA”)
- 2005 - acquires Butler Research Group Limited and Verdict Research Limited
- 2004 - acquires MIS, Benchmarkers Limited and Productscan Online
- 2002 - acquires Computerwire, and also opened offices in Tokyo and San Francisco
- 2000 - floated on the London Stock Exchange
- 1999 - opens offices in Frankfurt and Hong Kong
- 1995 - opens its New York office
- 1989 - founded in the United Kingdom
[edit] References
- ^ Contact us. Datamonitor.com. Retrieved on January 22, 2007.
- ^ Standfield, Robert. "What Will They Think of Next?", Daily Record (UK), 2006-01-12. Retrieved on January 16, 2007.
- ^ Thornton, Philip. "India put on hold as Africa challenges to be the latest outsourcing hotspot", The Independent, 6 June 2006. Retrieved on January 22, 2007.
- ^ "Dark continent in call centre spotlight", New Zealand Herald, 8 June 2006. Retrieved on January 22, 2007.
- ^ Smith, Aaron. "Glaxo to remain the asthma king - Analysts say that the Advair/Serevent franchise won't get blown away by Singulair or Symbicort.", CNN Money, 15 May 2006. Retrieved on January 22, 2007.
[edit] External links
 |
This corporation or company article is a stub. You can help Wikipedia by expanding it. |
